Paul R. Edick
See Remarks at Xeris Biopharma Holdings Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Xeris Biopharma Holdings Inc., 3 years.
Xeris Biopharma Holdings Inc.
Director · See Remarks
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 31, 2024 | Xeris Biopharma Holdings Inc. | Grant or award | +1,500,000 | — | — |
| Aug 9, 2023 | Xeris Biopharma Holdings Inc. | Open-market purchase | +10,000 | $2.38 | $23,800 |
| Jan 31, 2023 | Xeris Biopharma Holdings Inc. | Grant or award | +750,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.